Xiamen Kingdomway Group (002626.SZ) announced that its wholly-owned subsidiary, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (hereinafter referred to as Kingdomway Pharmaceutical), has recently received the "Food Production License" issued by the Administrative Approval and Public Service Bureau of Hohhot City. This license allows the production of "Pyridoxine Quinone Disodium Salt" and "Inositol".
Jindawei (002626.SZ) announced that its wholly-owned subsidiary, Inner Mongolia Jindawei Pharmaceutical Co., Ltd. (hereinafter referred to as Jindawei Pharmaceutical), recently received the "Food Production License" issued by the Administrative Approval and Public Service Bureau of Hohhot City. This license allows the production of "Pyridoxine Quinone Disodium Salt" and "Inositol".
The acquisition of a food production license for Pyridoxine Quinone Disodium Salt and Inositol projects is beneficial to the optimization of the company's product structure and the enrichment of the company's product layout, further enhancing the company's core competitiveness. The market promotion of the new products will take some time, and it is expected to have no major impact on the company's performance this year.